Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
incretin hormones
Email alerts
incretin hormones
Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on study
Kosuke Robert
Shima
,
Tsuguhito
Ota
,
Ken-ichiro
Kato
,
Yumie
Takeshita
,
Hirofumi
Misu
,
Shuichi
Kaneko
,
Toshinari
Takamura
BMJ Open Diabetes Research and Care
Mar 2018,
6
(1)
e000469;
DOI:
10.1136/bmjdrc-2017-000469
Special collections
BMJ Open Diabetes Research and Care
Cardiovascular and metabolic risk
(31)
Clinical care/education/nutrition/psychosocial research
(56)
Emerging technologies and therapeutics
(6)
Epidemiology/health services research
(84)
Genetics/genomes/proteomics/metabolomics
(2)
Immunology and transplantation
(2)
Islet studies
(3)
Metabolism
(10)
Methodology review(s)
Obesity studies
(10)
Pathophysiology/complications
(24)
Pharmacology and therapeutics
(6)
Signal transduction
Technological advances
(1)
Guidelines, Recommendations and Consensus Statements
Press releases
(4)